James E. Fickenscher is CFO at AUXILIUM PHARMACEUTICALS INC (AUXL). They have made 11 open-market trades across 3 companies since 2006, most recently 2023-10-10.
CIK 0001327442
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $552K since 2006, against 3 sales. Across 5 scored buys the stock is down 4.1% at ninety days, and 5.4 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 60% | 40% |
| Avg Move | -5.0% | +3.9% | -4.1% |
| Alpha | -4.5% | +2.4% | -5.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZYNE | SELL | 2023-09-13 | 2023-09-14 | $1.33 | $12K | -3.8% | N/A | N/A |
| ZYNE | SELL | 2023-01-23 | 2023-01-25 | $0.60 | $11K | -1.6% | -16.1% | -40.7% |
| ZYNE | SELL | 2022-07-19 | 2022-07-20 | $1.10 | $7K | -7.2% | -2.4% | -45.3% |
| ZYNE | BUY | 2018-08-06 | 2018-08-07 | $5.97 | $102K | -3.4% | +13.2% | -9.4% |
| ZYNE | BUY | 2017-05-12 | 2017-05-16 | $19.82 | $103K | -2.4% | -13.4% | -67.0% |
| ZYNE | BUY | 2016-12-06 | 2016-12-08 | $14.08 | $99K | -7.9% | +13.6% | +32.6% |
| ATRS | BUY | 2016-03-18 | 2016-03-21 | $0.72 | $97K | +10.9% | +8.3% | +25.6% |
| ATRS | BUY | 2014-12-11 | 2014-12-15 | $2.50 | $100K | -22.0% | -2.5% | -2.5% |
| AUXL | SELL · 10b5-1 | 2013-12-11 | 2013-12-12 | $20.37 | $1.4M | N/A | N/A | N/A |
| AUXL | BUY | 2011-11-03 | 2011-11-07 | $15.54 | $25K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-09-14 | 2009-09-16 | $30.70 | $123K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-09-08 | 2009-09-10 | $30.00 | $120K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-07-15 | 2009-07-17 | $30.01 | $120K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-06-15 | 2009-06-17 | $27.21 | $109K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-05-22 | 2009-05-27 | $25.02 | $100K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-04-16 | 2009-04-20 | $25.01 | $100K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-03-16 | 2009-03-17 | $29.79 | $147K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-02-17 | 2009-02-19 | $31.55 | $109K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2009-01-14 | 2009-01-16 | $29.04 | $114K | N/A | N/A | N/A |
| AUXL | SELL · 10b5-1 | 2008-12-19 | 2008-12-22 | $26.31 | $307K | N/A | N/A | N/A |
| AUXL | BUY | 2007-05-08 | 2007-05-10 | $13.38 | $20K | N/A | N/A | N/A |
| AUXL | BUY | 2006-03-10 | 2006-03-14 | $6.43 | $6K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.